Herein, we observed that the presence of active CD56/CREB1 signaling in MM cells is associated with an increase of inhibitory NKG2A+CD94+ NK cells, similarly to the phenotype observed in patients with t(4;14) [11]. This evidence concerns the gene NCAM1 and Miyoshi myopathy.